Literature DB >> 25005121

Diabetic gastroparesis: functional/morphologic background, diagnosis, and treatment options.

Viktor J Horváth1, Ferenc Izbéki, Csaba Lengyel, Péter Kempler, Tamás Várkonyi.   

Abstract

The regulation of gastrointestinal motility mainly involves the smooth muscle, neural (extrinsic and intrinsic), and hormonal elements, the glial cells, and the interstitial cells of Cajal. An orchestrated function of all these components is required for the appropriate propulsive movement of the food in the gastrointestinal tract. Gastroparesis, a pathological slowing-down of gastric emptying, is a result of the damage to the tissue elements involved in the regulation of motility. Gastroparesis is one of the well-known complications of long-standing diabetes mellitus. Although it is rarely a life-threatening complication, it has a deteriorating effect on the quality of life, leads to unpredictable oscillation of the blood glucose level, and increases the time required for the absorption of food and medicines. This review describes the clinical characteristics of diabetic gastroparesis and summarizes the organic and functional motility abnormalities caused by this complication. Finally, the currently available and potential future therapeutic approaches are summarized.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25005121     DOI: 10.1007/s11892-014-0527-8

Source DB:  PubMed          Journal:  Curr Diab Rep        ISSN: 1534-4827            Impact factor:   4.810


  93 in total

1.  Physiological hyperglycemia slows gastric emptying in normal subjects and patients with insulin-dependent diabetes mellitus.

Authors:  E Schvarcz; M Palmér; J Aman; M Horowitz; M Stridsberg; C Berne
Journal:  Gastroenterology       Date:  1997-07       Impact factor: 22.682

Review 2.  Current options and perspectives in the treatment of diabetic neuropathy.

Authors:  Tamás Várkonyi; Zsuzsanna Putz; Katalin Keresztes; Tímea Martos; Csaba Lengyel; Alin Stirban; György Jermendy; Peter Kempler
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

3.  Clinical response and side effects of metoclopramide: associations with clinical, demographic, and pharmacogenetic parameters.

Authors:  Henry P Parkman; Anurag Mishra; Michael Jacobs; Murali Pathikonda; Priyanka Sachdeva; John Gaughan; Evgeny Krynetskiy
Journal:  J Clin Gastroenterol       Date:  2012-07       Impact factor: 3.062

4.  Abnormal ghrelin and pancreatic polypeptide responses in gastroparesis.

Authors:  Kishore V Gaddipati; Hrair P Simonian; Karen M Kresge; Guenther H Boden; Henry P Parkman
Journal:  Dig Dis Sci       Date:  2006-07-26       Impact factor: 3.199

5.  Demography, clinical characteristics, psychological and abuse profiles, treatment, and long-term follow-up of patients with gastroparesis.

Authors:  I Soykan; B Sivri; I Sarosiek; B Kiernan; R W McCallum
Journal:  Dig Dis Sci       Date:  1998-11       Impact factor: 3.199

6.  Jejunostomy tube placement in refractory diabetic gastroparesis: a retrospective review.

Authors:  R J Fontana; J L Barnett
Journal:  Am J Gastroenterol       Date:  1996-10       Impact factor: 10.864

7.  Hyperglycemia affects cardiovascular autonomic nerve function in normal subjects.

Authors:  B B Yeap; A Russo; R J Fraser; G A Wittert; M Horowitz
Journal:  Diabetes Care       Date:  1996-08       Impact factor: 19.112

Review 8.  Interstitial cells of Cajal in diabetic gastroenteropathy.

Authors:  T Ordög
Journal:  Neurogastroenterol Motil       Date:  2008-01       Impact factor: 3.598

9.  Metoclopramide therapy in patients with delayed gastric emptying: a randomized, double-blind study.

Authors:  M S Perkel; C Moore; T Hersh; E D Davidson
Journal:  Dig Dis Sci       Date:  1979-09       Impact factor: 3.199

Review 10.  Disorders of gastrointestinal motility associated with diabetes mellitus.

Authors:  M Feldman; L R Schiller
Journal:  Ann Intern Med       Date:  1983-03       Impact factor: 25.391

View more
  19 in total

1.  Gastrointestinal autonomic neuropathy in diabetes: the unattended borderline between diabetology and gastroenterology.

Authors:  Péter Kempler; Tamás Várkonyi; Anna E Körei; Viktor J Horváth
Journal:  Diabetologia       Date:  2015-12-05       Impact factor: 10.122

2.  Severe gastrointestinal autonomic dysfunction in a diabetic boy.

Authors:  Pedro Marques; Luís Varandas; Lurdes Lopes
Journal:  Endocrine       Date:  2015-03-10       Impact factor: 3.633

Review 3.  Diabetes-related dysfunction of the small intestine and the colon: focus on motility.

Authors:  Viktor József Horváth; Zsuzsanna Putz; Ferenc Izbéki; Anna Erzsébet Körei; László Gerő; Csaba Lengyel; Péter Kempler; Tamás Várkonyi
Journal:  Curr Diab Rep       Date:  2015-11       Impact factor: 4.810

Review 4.  Enhanced Recovery After Surgery (ERAS®) in Individuals with Diabetes: A Systematic Review.

Authors:  Zaina Albalawi; Michael Laffin; Leah Gramlich; Peter Senior; Finlay A McAlister
Journal:  World J Surg       Date:  2017-08       Impact factor: 3.352

5.  Impact of preoperative carbohydrate loading on gastric volume in patients with type 2 diabetes.

Authors:  Xin-Qiang Lin; Yu-Ren Chen; Xiao Chen; Yu-Ping Cai; Jian-Xin Lin; De-Ming Xu; Xiao-Chun Zheng
Journal:  World J Clin Cases       Date:  2022-06-26       Impact factor: 1.534

6.  Esophageal and Gastric Dysmotilities are Associated with Altered Glucose Homeostasis and Plasma Levels of Incretins and Leptin.

Authors:  Rebecka Hammersjö; Bodil Roth; Peter Höglund; Bodil Ohlsson
Journal:  Rev Diabet Stud       Date:  2016-05-10

Review 7.  Assessment of the cardiovascular and gastrointestinal autonomic complications of diabetes.

Authors:  Christina Brock; Birgitte Brock; Anne Grave Pedersen; Asbjørn Mohr Drewes; Niels Jessen; Adam D Farmer
Journal:  World J Diabetes       Date:  2016-08-25

8.  Mechanism of CNP-mediated DG-PKC and IP4 signaling pathway in diabetic rats with gastric motility disorder.

Authors:  Hui-Ming Lian; Jun-Yu Guo; Yan Sun; Mo-Han Zhang; Li-Hua Piao; Zheng Jin; Ying-Lan Cai
Journal:  Mol Biol Rep       Date:  2019-10-03       Impact factor: 2.316

Review 9.  The role of intestinal bacteria overgrowth in obesity-related nonalcoholic fatty liver disease.

Authors:  Silvia M Ferolla; Geyza N A Armiliato; Cláudia A Couto; Teresa C A Ferrari
Journal:  Nutrients       Date:  2014-12-03       Impact factor: 5.717

10.  Effects of Rebamipide on Gastrointestinal Symptoms in Patients with Type 2 Diabetes Mellitus.

Authors:  Sejeong Park; So Young Park; Yu Jin Kim; Soo Min Hong; Suk Chon; Seungjoon Oh; Jeong Taek Woo; Sung Woon Kim; Young Seol Kim; Sang Youl Rhee
Journal:  Diabetes Metab J       Date:  2016-04-21       Impact factor: 5.376

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.